Hikal Limited (NSE:HIKAL)
India · Delayed Price · Currency is INR 225.50
+0.10 (0.04%)
Nov 11, 2026, 1:30 PM IST
Hikal Market Cap
Hikal has a market cap or net worth of 27.77 billion as of November 10, 2026. Its market cap has decreased by 2.83% in one year.
Market Cap
27.77B
Enterprise Value
33.93B
Revenue
18.51B
Global Rank
n/a
Country Rank
n/a
PE Ratio
n/a
ChartMarket Cap Chart
Since May 6, 2002, Hikal's market cap has increased from 1.36B to 27.77B, an increase of 1,946.37%. That is a compound annual growth rate of 13.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 27.77B | -0.73% |
| Dec 31, 2025 | 27.98B | -41.82% |
| Dec 31, 2024 | 48.09B | 28.50% |
| Dec 29, 2023 | 37.42B | -26.02% |
| Dec 30, 2022 | 50.58B | -22.11% |
| Dec 31, 2021 | 64.94B | 219.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Innova Captab | 61.17B |
| Orchid Pharma | 52.94B |
| RPG Life Sciences | 42.94B |
| Solara Active Pharma Sciences | 31.27B |
| Ind-Swift Laboratories | 30.35B |
| Sakar Healthcare | 22.89B |
| Indoco Remedies | 20.25B |
| Windlas Biotech | 20.10B |